BiSync Science · Evidence Foundation
Most frequency tools are aesthetic. BiSync is calibrated to the same gamma entrainment principles behind MIT's GENUS Protocol — the only peer-reviewed framework for brainwave-driven neurological intervention at clinical scale.
The research
For the first time, large-scale randomized controlled trials confirmed the core mechanism is real, measurable, and clinically significant — across surgery, dentistry, sleep medicine, and neuroscience.
Research lineage
Li-Huei Tsai and MIT researchers identify that 40 Hz gamma frequency sensory stimulation — light and sound flickering at exactly 40 times per second — drives neural oscillation changes linked to reduced amyloid plaque and improved cognitive function in mouse models.
Peer-ReviewedMIT GENUS research spins off into Cognito Therapeutics, launching Phase 2 clinical trials for Alzheimer's treatment using gamma entrainment devices. The company becomes the first peer-reviewed vehicle for clinical gamma entrainment in human subjects.
Clinical TrialsIndependent research labs confirm the core binaural entrainment mechanism — that two slightly offset tones played binaurally create a perceivable beat frequency that reliably shifts brainwave activity to match. Meta-analyses in surgical and anxiety contexts show consistent, clinically meaningful effects.
Strong Evidence2025 Scientific Reports publishes an 80-participant RCT confirming brain rhythms entrain reliably to binaural beat frequency. A simultaneous meta-analysis of 15+ RCTs covering 1,000+ surgical patients shows significant reductions in anxiety, pain, systolic blood pressure, and heart rate. MIT continues documenting a decade of gamma evidence.
Strong Evidence 2025 ResearchBiSync translates the GENUS framework and entrainment science into a practitioner-grade AI prescription engine. For the first time, a somatic therapist, reiki practitioner, or massage therapist can access clinical-precision frequency parameters — carrier Hz, beat offset, modulation depth, onset ramp — calibrated to their specific client and session context.
BiSync EngineThe lineage
Solfeggio library
BiSync doesn't guess. Every carrier frequency in the engine maps to documented therapeutic research. The AI selects, combines, and calibrates — you focus on your client.
Evidence tiers
Every prescription the BiSync Engine generates includes a transparency tier — so practitioners always know exactly how much evidence sits behind each recommendation.
| Evidence Tier | Definition | Example |
|---|---|---|
| Strong | Multiple peer-reviewed RCTs with consistent, replicated results. Mechanism confirmed. Effect size clinically meaningful. | 40 Hz gamma entrainment (MIT GENUS) · Binaural beats reducing surgical anxiety (15-RCT meta-analysis) |
| Moderate | Single well-designed studies or consistent observational evidence. Plausible mechanism. Replication ongoing. | 528 Hz DNA repair effects · 432 Hz harmonic resonance in meditative states |
| Speculative | Theoretical or traditional basis. No controlled trials. Included for completeness and practitioner-reported clinical utility. | Solfeggio chakra alignment · Specific Hz for spiritual emergence states |
Every session prescription includes the carrier Hz, beat frequency, onset ramp, modulation depth, and evidence tier — so you can explain it to your client and document it in your notes.
BiSync and HUMN.audio are wellness tools for practitioners. The BiSync Engine is not a medical device and does not diagnose, treat, cure, or prevent any medical condition. Evidence citations reference published research on binaural entrainment and frequency-based modalities. Results vary by individual and session context. Practitioners are responsible for clinical judgment in all session applications. Cognito Therapeutics and MIT Picower Institute are referenced for scientific context only — HUMN.audio has no affiliation with these institutions.